Pivotal Bioventure Partners Investment Advisor LLC Top Holdings and 13F Report (2025) About Pivotal Bioventure Partners Investment Advisor LLCInvestment ActivityPivotal Bioventure Partners Investment Advisor LLC has $161.34 million in total holdings as of June 30, 2025.Pivotal Bioventure Partners Investment Advisor LLC owns shares of 12 different stocks, but just 4 companies or ETFs make up 80% of its holdings.Approximately 16.46% of the portfolio was purchased this quarter.About 0.47% of the portfolio was sold this quarter.This quarter, Pivotal Bioventure Partners Investment Advisor LLC has purchased 11 new stocks and bought additional shares in 2 stocks.Pivotal Bioventure Partners Investment Advisor LLC sold shares of 0 stocks and completely divested from 1 stock this quarter.Largest Holdings Oculis $44,658,023Vaxcyte $42,429,614Arcutis Biotherapeutics $29,729,522Inozyme Pharma $17,979,404ZENAS BIOPHARMA INC $7,548,946 Largest New Holdings this Quarter 89532M101 - Trevi Therapeutics $6,269,222 Holding097702203 - BOLT BIOTHERAPEUTICS INC $545,686 Holding Largest Purchases this Quarter Vaxcyte 594,391 shares (about $19.32M)Trevi Therapeutics 1,146,110 shares (about $6.27M)BOLT BIOTHERAPEUTICS INC 94,573 shares (about $545.69K)ZENAS BIOPHARMA INC 42,400 shares (about $410.86K) Sector Allocation Over TimeMap of 500 Largest Holdings ofPivotal Bioventure Partners Investment Advisor LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorOCSOculis$44,658,0230.0%2,300,77427.7%MedicalPCVXVaxcyte$42,429,614$19,323,652 ▲83.6%1,305,12526.3%MedicalARQTArcutis Biotherapeutics$29,729,5220.0%2,120,50818.4%MedicalINZYInozyme Pharma$17,979,4040.0%4,494,85111.1%MedicalZENAS BIOPHARMA INC$7,548,946$410,856 ▲5.8%779,0454.7%COMTRVITrevi Therapeutics$6,269,222$6,269,222 ▲New Holding1,146,1103.9%MedicalVIGLVigil Neuroscience$4,456,7300.0%560,5952.8%MedicalRXRXRecursion Pharmaceuticals$3,013,3210.0%595,5181.9%MedicalBIOAGE LABS INC$2,698,4350.0%653,3741.7%COMIOBTIO Biotech$1,201,2340.0%864,1970.7%MedicalRLYBRallybio$812,7700.0%2,404,6440.5%MedicalBOLT BIOTHERAPEUTICS INC$545,686$545,686 ▲New Holding94,5730.3%COM NEWBOLTBolt Biotherapeutics$0$756,587 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access